Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligands.
A new approach of competitive displacement binding assay using brain sections and a beta-imager is presented to estimate binding parameters such as affinity and selectivity of new compounds or to characterize receptor families or subtypes of receptors in small brain regions. This method includes a preliminary saturation assay intended to define the optimal concentration of displaceable radio-labeled ligand followed by the determination of displacement constants (IC(50) and K(i)) in cerebral regions rich in studied receptor. The technique application was demonstrated in seven rat brain structures, using displacement of the selective tritiated mu-opioid ligand [(3)H]-DAMGO by six opioid ligands: a specific agonist (DAMGO), less specific agonists (morphine, remifentanil), a non-specific antagonist with good affinity for mu receptors (naloxone) and ligands specific of other opioid subtypes (naltrindole, U50.488). Radioactivity counts were collected during 48 h. The assay-validation was performed by measuring intra- and inter-assay variation on determinations and by comparing presently obtained K(i) values with data from recognised methodologies. Both prove the accuracy of the proposed method.
Poisnel
Géraldine
G
UMR CEA-2-FRE-CNRS 2698 Research group, Center Cyceron, Caen, France. poisnel@cyceron.fr
Quentin
Thomas
T
Barré
Louisa
L
Coquerel
Antoine
A
Debruyne
Danièle
D
D000701:Analgesics, Opioid / Q000493:pharmacokinetics; D000818:Animals; D001345:Autoradiography / Q000379:methods*; D001610:Beta Particles; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D003952:Diagnostic Imaging / Q000379:methods*; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000493:pharmacokinetics; D006651:Histocytochemistry; D007553:Isotope Labeling; D007700:Kinetics; D008024:Ligands; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D017465:Receptors, Opioid, delta / Q000819:agonists / Q000037:antagonists & inhibitors; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors; D017450:Receptors, Opioid, mu / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015203:Reproducibility of Results; D014316:Tritium
D000701:Analgesics, Opioid; D008024:Ligands; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D014316:Tritium; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-